The results above demonstrate that increasing TFEB nuclear translocation, either through mTOR inhibition at the post-translational level or TFEB overexpression at the transcriptional level, can enhance ALP-targeted clearance of proteins related to AD. Here, MTOR is linked to Alzheimer disease.